Company Data

Wound Mgt Techs Inc

Ticker
WNDM
Market Cap
$65.0M
Price Target
Refer to Report
Volume
697.8K
52wk Range
$0.1144 - $0.467
Advanced Market Data

Overview

Wound Management Technologies Inc is a provider of the patented CellerateRX Activated Collagen product in the wound care and surgical markets. The CellerateRX is developed for use on all acute and chronic wounds and is offered in both gel and powder form. The company engages in the distribution of collagen-based wound care products to healthcare providers such as physicians, clinics, and hospitals. The other product brand of the company includes Hemaquell which provides hemostasis by filling in cut or damaged bone surfaces with a ready-to-use application.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.